Investor Bristol Myers Squibb Co
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Bristol Myers Squibb Co . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-02-14 13G/A CGEN / Compugen Ltd. 4,757,058 1,840,136
2025-02-14 13G/A QTTB / Q32 Bio Inc. 759,145 200,244
2025-02-14 13G/A 11,953,274 426,372
2024-11-13 13G QTTB / Q32 Bio Inc. 759,145
2024-11-13 13G/A IKNA / Ikena Oncology, Inc. 2,133,142 2,133,142
2024-11-13 13G/A QURE / uniQure N.V. 2,388,108 2,388,108
2024-11-13 13G/A RNA / Avidity Biosciences, Inc. 5,075,304 5,075,304
2024-10-04 13G PRME / Prime Medicine, Inc. 11,006,163
2023-12-04 13G RNA / Avidity Biosciences, Inc. 5,075,304
2021-11-19 13G CGEN / Compugen Ltd. 4,757,058
2021-07-26 13G CELU / Celularity Inc. 11,953,274
2021-04-05 13G/A STRO / Sutro Biopharma, Inc. 1,726,197
2021-04-05 13G/A IDYA / IDEAYA Biosciences, Inc. 1,633,254
2021-04-05 13D/A AGIO / Agios Pharmaceuticals, Inc. 0
2021-04-05 13G/A JNCE / Jounce Therapeutics Inc 3,456,463
2021-04-05 13G IKNA / Ikena Oncology, Inc. 2,133,142
2020-07-16 13D/A XLRN / Acceleron Pharma Inc 7,008,510
2015-08-17 13G/A QURE / uniQure N.V. 1,112,319 2,388,108
2015-06-22 13G QURE / uniQure N.V. 1,112,319
2015-02-13 13G/A ALDR / Alder BioPharmaceuticals, Inc. 0
2015-02-13 13G/A KBPH / K2X Technology & Life Science, Inc. 1,300,000
2014-10-06 13G KBPH / K2X Technology & Life Science, Inc. 1,300,000
2014-05-19 13G ALDR / Alder BioPharmaceuticals, Inc. 1,600,000
2012-02-13 13D/A INHX / Inhibitex, Inc.
2012-02-06 13D/A INHX / Inhibitex, Inc.
2012-02-03 13D/A INHX / Inhibitex, Inc.
2012-01-27 13D/A INHX / Inhibitex, Inc.
2012-01-19 13D/A INHX / Inhibitex, Inc.
2012-01-13 13D INHX / Inhibitex, Inc. 11,366,692